{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T23:22:31Z","timestamp":1767914551257,"version":"3.49.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.4158\/ep.11.5.319","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T21:38:11Z","timestamp":1365197891000},"page":"319-324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Polycystic Ovary Syndrome and Severe Nonalcoholic Steatohepatitis: Beneficial Effect of Modest Weight Loss and Exercise on Liver Biopsy Findings"],"prefix":"10.1016","volume":"11","author":[{"given":"Ann J.","family":"Brown","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Tendler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert G.","family":"McMurray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy L.","family":"Setji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP.11.5.319_bb0005","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1210\/jcem-65-3-499","article-title":"Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and\/or hyperinsulinemia","volume":"65","author":"Dunaif","year":"1987","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.11.5.319_bb0010","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0889-8529(05)70069-4","article-title":"The epidemiology of polycystic ovary syndrome: prevalence and associated disease risks","volume":"28","author":"Solomon","year":"1999","journal-title":"Endocrinol Metab Clin North Am."},{"key":"10.4158\/EP.11.5.319_bb0015","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0002-9343(01)00948-2","article-title":"Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome","volume":"111","author":"Legro","year":"2001","journal-title":"Am J Med."},{"key":"10.4158\/EP.11.5.319_bb0020","first-page":"3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.11.5.319_bb0025","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease: a spectrum of clinical pathological severity","volume":"116","author":"Matteoni","year":"1999","journal-title":"Gastroenterology."},{"key":"10.4158\/EP.11.5.319_bb0030","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/hep.510290347","article-title":"Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease","volume":"29","author":"Caldwell","year":"1999","journal-title":"Hepatology."},{"key":"10.4158\/EP.11.5.319_bb0035","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-126-2-199701150-00008","article-title":"Nonalcoholic steato-hepatitis [erratum in Ann Intern Med. 1997;127(8 Pt 1):658]","volume":"126","author":"Sheth","year":"1997","journal-title":"Ann Intern Med."},{"key":"10.4158\/EP.11.5.319_bb0040","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1053\/jhep.2002.30692","article-title":"NASH and insulin resistance: insulin hypersecretion and specific association with insulin resistance syndrome","volume":"35","author":"Chitturi","year":"2002","journal-title":"Hepatology."},{"key":"10.4158\/EP.11.5.319_bb0045","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/jhep.2002.30690","article-title":"Nonalcoholic steato-hepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association","volume":"35","author":"Pagano","year":"2002","journal-title":"Hepatology."},{"key":"10.4158\/EP.11.5.319_bb0050","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0889-8529(05)70076-1","article-title":"Diagnosis of polycystic ovary syndrome","volume":"28","author":"Chang","year":"1999","journal-title":"Endocrinol Metab Clin North Am."},{"key":"10.4158\/EP.11.5.319_bb0055","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1046\/j.1365-2265.2001.01303.x","article-title":"Tissue insulin sensitivity and body weight in polycystic ovary syndrome","volume":"55","author":"Marsden","year":"2001","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.4158\/EP.11.5.319_bb0060","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes melli-tus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.11.5.319_bb0065","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes."},{"key":"10.4158\/EP.11.5.319_bb0070","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0889-8529(05)70074-8","article-title":"Insulin action in the normal and polycystic ovary","volume":"28","author":"Franks","year":"1999","journal-title":"Endocrinol Metab Clin North Am."},{"key":"10.4158\/EP.11.5.319_bb0075","first-page":"2001","article-title":"Insulin stimulates testosterone biosynthesis by human theca cells from women with poly-cystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system","volume":"83","author":"Nestler","year":"1998","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.11.5.319_bb0080","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1210\/jcem-68-6-1027","article-title":"Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome","volume":"68","author":"Nestler","year":"1989","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.11.5.319_bb0085","first-page":"139","article-title":"Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation","volume":"85","author":"Moghetti","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.11.5.319_bb0090","first-page":"3299","article-title":"The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome","volume":"81","author":"Dunaif","year":"1996","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.11.5.319_bb0095","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0015-0282(99)00468-9","article-title":"Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity","volume":"73","author":"Mather","year":"2000","journal-title":"Fertil Steril."},{"key":"10.4158\/EP.11.5.319_bb0100","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/79697","article-title":"Metformin reverses fatty liver disease in obese, leptin-deficient mice","volume":"6","author":"Lin","year":"2000","journal-title":"Nat Med."},{"key":"10.4158\/EP.11.5.319_bb0105","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1572-0241.2001.03553.x","article-title":"A pilot study of a thiazolidine-dione, troglitazone, in nonalcoholic steatohepatitis","volume":"96","author":"Caldwell","year":"2001","journal-title":"Am J Gastroenterol."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20401922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20401922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/6D208RCRPVAM4W7N.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:44:58Z","timestamp":1761515098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20401922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S1530891X20401922"],"URL":"https:\/\/doi.org\/10.4158\/ep.11.5.319","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polycystic Ovary Syndrome and Severe Nonalcoholic Steatohepatitis: Beneficial Effect of Modest Weight Loss and Exercise on Liver Biopsy Findings","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.11.5.319","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}